Bupivacaine Hydrochloride
Product Images NDC 59923-717

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Bupivacaine Hydrochloride (NDC 59923-717). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Areva Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-label (12.5 Carton)

Packaging label for Bupivacaine Fisiopharma 2.5 mg/ml injectable solution. The product contains 10 ampoules of 5 ml each. The label features the proprietary name, concentration, dosage form, package size, and the drug code N01BB01 Bupivacaine. The labeler is identified as Areva Pharmaceuticals, and the design includes a green and white color scheme with the Fisiopharma logo.*

FDA Label Image

Container-label (2.5mg 10ml)

Label for Bupivacaine Fisiopharma 2.5 mg/mL solution for injection in a 10 mL volume. The label shows the active ingredient as Bupivacaine. It includes batch and expiration placeholders and lists Fisiopharma S.r.l. as the labeler. An NDC code 59923-719-10 is visible.*

FDA Label Image

Carton-label (2.5mg 10ml Carton)

Packaging label for Bupivacaine Fisiopharma 2.5 mg/ml injectable solution. The label indicates a package of 10 ampoules, each containing 10 ml. The label includes active ingredient information, storage instructions, and manufacturer details: Fisiopharma srl, Italy. It features a blue and white design with the brand name prominently displayed.*

FDA Label Image

Container-label (2.5mg 5ml)

Label for Bupivacaine Fisiopharma 2.5 mg/mL solution for injection, 5 mL. The label includes batch number, expiration date format, and NDC 59923-717-05. Manufactured by Fisiopharma S.r.l.*

FDA Label Image

Carton-label (25mg Carton)

Packaging label for Bupivacaina Fisiopharma 5 mg/ml injectable solution. The label states the product contains 10 ampoules of 5 ml each. The active ingredient is bupivacaine. The label design includes orange accents and the Fisiopharma logo. The labeler is Areva Pharmaceuticals, and the product is identified by code N01BB01.*

FDA Label Image

Carton-label (25mg Label)

Label for Marcaine 0.25% (bupivacaine HCl injection, USP) 25 mg/10 mL (2.5 mg/mL) preservative-free single-dose vial. Indicated for infiltration, nerve block, caudal, and epidural anesthesia, not for spinal anesthesia. Manufactured by Hospira, Inc., Lake Forest, IL USA. Includes NDC 0409-1559-18, storage instructions, and barcode.*

FDA Label Image

Carton Label (50mg Carton)

Packaging label for Bupivacaina Fisiopharma 5 mg/ml injectable solution. The label indicates a box containing 10 ampoules of 10 ml each. Active ingredient noted is bupivacaine hydrochloride 5 mg per ml. The label includes manufacturer information for Fisiopharma srl in Italy, usage and storage instructions, and environmental disposal warnings. The design includes blue and white colors with a stylized graphic.*

FDA Label Image

Carton-label (50mg Label)

Label for Marcaine 0.5% bupivacaine HCl injection, USP, 50 mg/10 mL (5 mg/mL), preservative-free single-dose vial. Intended for nerve block, caudal, and epidural anesthesia. Label includes usage warnings and the manufacturer Hospira, Inc., Lake Forest, IL.*

FDA Label Image

Container Label (5mg 10ml)

Bupivacaine Fisiopharma 5 mg/ml solution for injection in a 10 ml container. The label shows the batch number placeholder, expiration date placeholder, and the NDC 59923-720-10. The manufacturer is Fisiopharma S.r.l.*

FDA Label Image

Container-label (5mg 5ml)

Label of Bupivacaine Fisiopharma 5 mg/mL solution for injection in a 5 mL vial. The label shows the proprietary name, concentration, dosage form, batch number placeholder, expiration date placeholder, NDC 59923-718-05, and the manufacturer Fisiopharma S.r.l.*

FDA Label Image

Table1 (Table1)

A table titled 'Recommended Concentrations and Doses of MARCAINE' showing types of nerve blocks with corresponding concentrations, dose volumes, and doses in milligrams for Bupivacaine Hydrochloride. The table details local infiltration, epidural, caudal, peripheral nerves, retrobulbar, sympathetic, dental, and epidural test doses, along with notes on motor block effects and administration guidance.*

FDA Label Image

Table2 (Table2)

A data table presenting examples of drug classes and corresponding drugs. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs, with examples listed for each category such as bupivacaine under Local anesthetics.*

FDA Label Image

Table3 (Table3)

A dosage table listing various types of anesthesia using Bupivacaine Hydrochloride, with columns for concentration (mg/mL), dose in mL, and dose in mg. Types include trigeminal nerve block, axillary block, stellate ganglion, intercostal block, epidural block, continuous epidural block, sacral block, splanchnic nerve block, lumbar sympathetic block, intravenous retrograde block, pelvic block, and subarachnoidal spinal block, with varying concentrations and dose ranges.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.